iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
Status: | Completed |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/8/2017 |
Start Date: | September 2014 |
End Date: | September 2017 |
iChoose Kidney Decision Aid for Treatment Options Among End-Stage Renal Disease (ESRD) Patients
The investigators developed iChoose Kidney -- a shared decision-making support tool
accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers
with a simple, standardized, easily accessible, statistically robust tool for use in the
clinic to guide patient education and healthcare decision-making about treatment options of
dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with
estimates of their individualized 1 and 3-year risks of mortality on dialysis vs.
transplantation, based on previous national data. The tool has the potential to improve
communication and decision-making between patients and their healthcare providers and improve
access to kidney transplantation among patients with ESRD.
This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers
with diverse patient populations. One group of patients will receive standard education alone
during their scheduled transplant evaluation. The second group will receive the standard
education as well have the provider use the iChoose Kidney aid with them. The project
timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and
outcome evaluation.
This study will assess how well the iChoose decision aid works in improving patient
knowledge, preferences for treatment, and patient access to transplant. The study will also
assess whether providers find the tool useful for providing ways to share information with
patients about ways to treat their kidney disease.
accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers
with a simple, standardized, easily accessible, statistically robust tool for use in the
clinic to guide patient education and healthcare decision-making about treatment options of
dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with
estimates of their individualized 1 and 3-year risks of mortality on dialysis vs.
transplantation, based on previous national data. The tool has the potential to improve
communication and decision-making between patients and their healthcare providers and improve
access to kidney transplantation among patients with ESRD.
This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers
with diverse patient populations. One group of patients will receive standard education alone
during their scheduled transplant evaluation. The second group will receive the standard
education as well have the provider use the iChoose Kidney aid with them. The project
timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and
outcome evaluation.
This study will assess how well the iChoose decision aid works in improving patient
knowledge, preferences for treatment, and patient access to transplant. The study will also
assess whether providers find the tool useful for providing ways to share information with
patients about ways to treat their kidney disease.
Inclusion Criteria:
- Diagnosis of end-stage renal disease (ESRD) and on dialysis for < 1 year
- English-speaking
- Subjects coming in for transplant medical evaluation
- Age > 18 years
Exclusion Criteria:
- Severe cognitive or visual impairment
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials